SUMMARY A fetal tachyarrhythmia was discovered at the thirty-second week of gestation of a 22-yearold woman. Fetal echocardiography revealed atrial fibrillation with rapid ventricular rate, without any other demonstrable cardiac abnormality. In spite of therapeutic maternal blood levels of digoxin, the fetal ventricular rate and cardiac size increased, which prompted us to perform cesarean section at the thirtyfourth week of gestation. A baby with a Wolff-Parkinson-White syndrome but no other cardiac anomaly was delivered. Recurrent episodes of nonsustained atrial fibrillation with conduction over the accessory pathway occurred in the first hours of life. The Wolff-Parkinson-White pattern was not present on subsequent ECG recordings. The use of echocardiography in the diagnosis and management of this rare fetal tachyarrhythmia is emphasized.
first pregnancy was voluntarily interrupted and was complicated by uterine perforation that required surgical repair. During routine examination in the thirtysecond week of gestation, fetal cardiac tachyarrhythmia was noted by the family physician. The patient was referred to our Department of Obstetrics on December 6, 1980 . On admission, the maternal examination was unremarkable. The blood pressure was 110/ 80 mm Hg and the pulse rate 90 beats/min. The maternal ECG and echocardiogram were normal. Routine blood and urine examinations, glucose tolerance test and thyroid function tests were all normal. Evaluation of the fetal status using a standard B-scan examination did not reveal any abnormality. The age of the fetus was assessed to be 32 weeks of gestation. However, the fetal pulse was rapid (more than 200 beats/min) and irregular. Several attempts to record a fetal ECG failed.
Fetal M-mode and two-dimensional echocardiographic examinations were performed. One-dimensional echocardiograms were performed using an Electronics for Medicine VR12 ultrasonoscope and a 2.25-MHz transducer, collimated to 7.5 cm and pulsed with repetition rate of 1000 pulses/sec. Two-dimensional studies were obtained using an Aloka Echocardiography SSD 1105 mechanical sector scanner. This imaging system uses a hand-held, single-element, 3.5-MHz transducer with a variable scanning angle of 30-900 and variable scanning speed of 5-30 frames/sec. During the examination, the mother lay in a supine position. The fetal lie was determined using images of the fetal head, spine and liver. The total cardiac size was measured on the two-dimensional echocardiogram, as the distance from the right ventricular epicardial surface to the epicardial surface of the left ventricular posterior wall.6 Measurements of the cardiac size were made on each examination when the atrioventricular valves had just closed. The right and left ventricular inner diameters were measured from the M-mode recording. 7 The first fetal M-mode echocardiogram (December 8) demonstrated an irregular ventricular tachyarrhythmia (cycle length 240-420 msec) as visualized on the tricuspid valve movements ( fig. IA) . Irregular atrial tachyarrhythmia was also visualized on atrial wall movements. Whether these wall movements were those of the right or left atrium was undetermined. Later, the ventricular rhythm was regular (cycle length 240 msec) and the atrial rhythm was also regular at a rate twice the ventricular rate ( fig. 1B) fig. 2) .
In view of the findings of rapid atrial fibrillation without evident cardiac abnormality, we treated the fetus by administering digitalis to the mother. The initial dose was 0.25 mg twice daily. Fetal echocardiographic studies were performed on December 14, when the maternal digoxin blood level was 0.9 ng/ml. The echocardiogram revealed persistent atrial fibrillation with irregular ventricular rhythm (cycle length 240-420 msec), marked biventricular enlargement, and increase of the total cardiac size ( fig. 3, table 1 The acceleration of the fetal ventricular rate while on therapeutic maternal blood levels of digoxin prompted us to perform cesarean section on the same day, in the thirty-fourth week of gestation.
A male baby that weighed 2500 g was delivered with no apparent complication. The Apgar score was 7 at 1 minute (mild cyanosis) and 9 at 5 minutes. The heart rate at delivery was irregular and rapid (about 200 beats/min). The placenta was unremarkable on macroscopic examination. The following digoxin levels were measured at the time of delivery: maternal blood 1.6 ng/ml, umbilical cord 1.6 ng/ml, fetal blood 1.6 ng/ml and amniotic fluid 0.6 ng/ml.
In the neonatal intensive care unit, the baby's general condition was satisfactory. At 10 minutes of age, slight peripheral cyanosis was present, the blood pressure was 40 mm Hg and the heart rate was regular at 170 beats/min. The liver was palpated 2 cm below the costal margin. A grade 2/6 systolic murmur was audible in the Erb area. The lungs were clear. The ECG revealed a normal sinus rhythm of 176 beats/min, with P waves of 3 mm amplitude, PR interval of 0.08 sec- Digoxin, 0.01 mg twice daily, was administered. No attacks of tachyarrhythmia occurred after the second day of life. On the thirtieth day, no signs of WPW were noted on the ECG (fig. 5B ). Normal sinus rhythm was present at 167 beats/min, with normal P waves; the PR interval was of 0.10 second without a delta wave. Incomplete right bundle branch block was present. The echocardiogram was normal. At 9 months of followup, the infant was asymptomatic and in excellent general condition. The cardiac examination was normal. The ECG showed a normal sinus rhythm without evidence of preexcitation.
Discussion
We believe that this is the first report of an infant with WPW and atrial fibrillation demonstrated in utero and during the early hours after birth.
Although a fetal ECG was not obtained, we believe that the intrauterine atrial fibrillation occurred with conduction over the accessory pathway for three reasons: the high ventricular rate during the tachyarrhythmia; the increase of the ventricular rate after giving the mother digitalis; and the recording of paroxysmal atrial fibrillation with conduction over the accessory pathway at the birth. A high ventricular rate could have resulted from enhanced atrioventricular nodal conduction2 due to enhanced sympathetic tone (secondary to congestive heart failure, for example) or to atrionodal bypass tracts. However, the fact that the tachyarrhythmia actually accelerated after maternal digoxin therapy makes this hypothesis unlikely.
Matemal digitalis administration is considered to be the therapy of choice in intrauterine tachyarrhythmias.i"0 Animal studies indicate that digoxin equilibrates across the placenta by passive diffusion.'1 These A~~C L7.FNOT-= 4e7-,,: S* studies have been confirmed in humans by the observation that fetal cord digoxin concentrations at term are similar to those in maternal venous blood.'2 This was noted in our case. In addition, as previously reported, 13 low digoxin levels were obtained in the mother during administration of digoxin at standard therapeutic dosages and high doses of digoxin were required to obtain therapeutic blood levels.
The use of digitalis has been shown to be dangerous during atrial fibrillation in patients with the WPW and 
